VF
FLNA

Virtu Financial’s Filana Therapeutics FLNA Stock Holding History

Virtu Financial’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32K Buy
+27,247
New +$38.8K ﹤0.01% 1292
2026
Q1 		– Sell
-48,832
Closed -$97K – 2219
2025
Q4 		$97K Buy
+48,832
New +$156K ﹤0.01% 1211
2025
Q2 		– Sell
-15,660
Closed -$23K – 1985
2025
Q1 		$23K Sell
15,660
-6,147
-28% -$15.5K ﹤0.01% 1091
2024
Q4 		$51K Buy
+21,807
New +$383K ﹤0.01% 1159
2024
Q1 		– Sell
-49,128
Closed -$1.11M – 2012
2023
Q4 		$1.11M Buy
49,128
+26,824
+120% +$567K 0.09% 184
2023
Q3 		$371K Buy
+22,304
New +$442K 0.04% 426
2023
Q1 		– Sell
-10,044
Closed -$297K – 2031
2022
Q4 		$297K Sell
10,044
-3,064
-23% -$110K 0.04% 501
2022
Q3 		$548K Buy
+13,108
New +$354K 0.05% 355
2021
Q3 		– Sell
-8,667
Closed -$741K – 1902
2021
Q2 		$741K Sell
8,667
-27,004
-76% -$1.45M 0.07% 311
2021
Q1 		$1.6M Buy
+35,671
New +$1.4M 0.11% 139
2019
Q3 		– Sell
-20,707
Closed -$25K – 1786
2019
Q2 		$25K Buy
20,707
+8,573
+71% +$9.72K ﹤0.01% 1320
2019
Q1 		$16K Sell
12,134
-22,386
-65% -$25.7K ﹤0.01% 1301
2018
Q4 		$29K Sell
34,520
-31,633
-48% -$36.4K ﹤0.01% 1339
2018
Q3 		$67K Buy
66,153
+46,628
+239% +$70.9K ﹤0.01% 1264
2018
Q2 		$40K Buy
+19,525
New +$167K ﹤0.01% 1795
2018
Q1 		– Sell
-15,866
Closed -$63K – 2503
2017
Q4 		$63K Buy
+15,866
New +$64.1K ﹤0.01% 2033

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Virtu Financial's FLNA Position: Q2 2026 in Review

Virtu Financial opened a new position in Filana Therapeutics (FLNA) in Q2 2026: 27,247 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #1292 among its holdings. This is a return to the name: Virtu Financial previously reported a position in FLNA as recently as Q4 2025.

Virtu Financial first reported a position in FLNA in Q4 2017 and has held it in 16 quarters since. The position peaked at $1.6M in Q1 2021. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Virtu Financial held 27,247 shares of Filana Therapeutics worth $32K as of Q2 2026.
  • Filana Therapeutics was a new Virtu Financial position in Q2 2026.
  • Filana Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1292 holding.
  • Virtu Financial first reported a position in Filana Therapeutics in Q4 2017 and has held it in 16 quarters since.
  • Virtu Financial's Filana Therapeutics position peaked at $1.6M in Q1 2021.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.